FACTORS ASSOCIATED WITH SUSTAINED REMISSION IN RHEUMATOID ARTHRITIS IN PATIENTS TREATED WITH ANTI-TUMOUR NECROSIS FACTOR: A SYSTEMATIC REVIEW

被引：0
作者：
Hamann, Philip [1 ]
Holland, Richard [2 ,3 ]
Hyrich, Kimme [4 ]
Pauling, John [2 ,3 ]
Shaddick, Gavin [5 ]
Nightingale, Alison [1 ]
McHugh, Neil [1 ]
机构：
[1] Univ Bath, Pharm & Pharmacol, Bath BA2 7AY, Avon, England
[2] Royal Natl Hosp Rheumat Dis, Rheumatol, Upper Borough Walls, Bath BA1 1RL, Avon, England
[3] Royal United Hosp, Bath BA1 3NG, Avon, England
[4] Univ Manchester, Arthrit Res UK Ctr Epidemiol, Manchester, Lancs, England
[5] Univ Bath, Math Sci, Bath BA2 7AY, Avon, England
来源：
RHEUMATOLOGY | 2016年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
093
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [31] DRUG SURVIVAL OF SECOND BIOLOGIC DMARD THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: COMPARISON OF A SECOND ANTI-TUMOUR NECROSIS FACTOR WITH A SECOND NON-ANTI-TUMOUR NECROSIS FACTOR AFTER DISCONTINUATION OF A FIRST ANTI-TUMOUR NECROSIS FACTOR
    Wilke, Thomas
    Mueller, Sabrina
    Majer, Istvan
    Heisen, Marieke
    Fuchs, Andreas
    Maywald, Ulf
    RHEUMATOLOGY, 2016, 55 : 105 - 105
  • [32] Long-term effects of anti-tumour necrosis factor therapy on weight in patients with rheumatoid arthritis
    Brown, Rachel A.
    Spina, Domenico
    Butt, Sayqa
    Summers, Gregory D.
    CLINICAL RHEUMATOLOGY, 2012, 31 (03) : 455 - 461
  • [33] Long-term effects of anti-tumour necrosis factor therapy on weight in patients with rheumatoid arthritis
    Rachel A. Brown
    Domenico Spina
    Sayqa Butt
    Gregory D. Summers
    Clinical Rheumatology, 2012, 31 : 455 - 461
  • [34] Varicella-zoster virus infection in rheumatoid arthritis patients in the anti-tumour necrosis factor era
    Cacciapaglia, F.
    Zuccaro, C.
    Iannone, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (06) : 917 - 923
  • [35] Anti-tumour necrosis factor alpha therapy normalises fibrinolysis impairment in patients with active rheumatoid arthritis
    Ingegnoli, F.
    Fantini, F.
    Griffini, S.
    Soldi, A.
    Meroni, P. L.
    Cugno, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : 254 - 257
  • [36] The Future Role of Anti-Tumour Necrosis Factor (TNF) Products in the Treatment of Rheumatoid Arthritis
    Giovanni Camussi
    Enrico Lupia
    Drugs, 1998, 55 : 613 - 620
  • [37] The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis
    Camussi, G
    Lupia, E
    DRUGS, 1998, 55 (05) : 613 - 620
  • [38] Definition of discontinuation of anti-tumour necrosis factor therapy in rheumatoid arthritis: a preliminary proposal
    Braun, J
    Sieper, J
    van der Heijde, D
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (10) : 1023 - 1024
  • [39] ANTI-TUMOUR NECROSIS FACTOR THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS DOES NOT ATTENUATE CUTANEOUS TUMOUR NECROSIS FACTOR ACTIVITY FOLLOWING A TUBERCULIN SKIN TEST
    Byng-Maddick, Rachel
    Haas, Carolin
    Ehrenstein, Michael
    Noursadeghi, Mahdad
    RHEUMATOLOGY, 2016, 55 : 146 - 146
  • [40] Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis
    Wijbrandts, C. A.
    van Leuven, S. I.
    Boom, H. D.
    Gerlag, D. M.
    Stroes, E. G. S.
    Kastelein, J. J. P.
    Tak, P. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (08) : 1316 - 1321
12345